Cell-based therapies for myocardial repair

Emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart

Jose S. Da Silva, Joshua Hare

Research output: Chapter in Book/Report/Conference proceedingChapter

16 Citations (Scopus)

Abstract

Accumulating data support the use of bone marrow (BM)-derived MSCs in animal models (e.g., swine) to restore cardiac function and tissue perfusion in chronic cardiac injury. Based on results obtained in swine, we are currently conducting phase I/II clinical trials to address the safety, cell type, cell dose, delivery technique, and efficacy of MSCs in patients with chronic heart failure. MSCs for these trials are isolated from harvested BM and then processed and expanded for intracardiac injection. The BM-MSCs in use for the clinical trials are of clinical grade having been processed successfully in an FDA-approved cGMP facility.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages145-163
Number of pages19
Volume1037
ISBN (Print)9781627035040
DOIs
StatePublished - 2013

Publication series

NameMethods in Molecular Biology
Volume1037
ISSN (Print)10643745

Fingerprint

Cell- and Tissue-Based Therapy
Mesenchymal Stromal Cells
Bone Marrow
Swine
Phase II Clinical Trials
Clinical Trials, Phase I
Therapeutics
Animal Models
Heart Failure
Perfusion
Clinical Trials
Safety
Injections
Wounds and Injuries

Keywords

  • BM MSC
  • cGMP
  • cGTP
  • CMC
  • FDA
  • HCT/P
  • HF
  • IND
  • MI

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Da Silva, J. S., & Hare, J. (2013). Cell-based therapies for myocardial repair: Emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart. In Methods in Molecular Biology (Vol. 1037, pp. 145-163). (Methods in Molecular Biology; Vol. 1037). Humana Press Inc.. https://doi.org/10.1007/978-1-62703-505-7_8

Cell-based therapies for myocardial repair : Emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart. / Da Silva, Jose S.; Hare, Joshua.

Methods in Molecular Biology. Vol. 1037 Humana Press Inc., 2013. p. 145-163 (Methods in Molecular Biology; Vol. 1037).

Research output: Chapter in Book/Report/Conference proceedingChapter

Da Silva, Jose S. ; Hare, Joshua. / Cell-based therapies for myocardial repair : Emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart. Methods in Molecular Biology. Vol. 1037 Humana Press Inc., 2013. pp. 145-163 (Methods in Molecular Biology).
@inbook{fc649b3503a64ad39f25931620f07a3e,
title = "Cell-based therapies for myocardial repair: Emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart",
abstract = "Accumulating data support the use of bone marrow (BM)-derived MSCs in animal models (e.g., swine) to restore cardiac function and tissue perfusion in chronic cardiac injury. Based on results obtained in swine, we are currently conducting phase I/II clinical trials to address the safety, cell type, cell dose, delivery technique, and efficacy of MSCs in patients with chronic heart failure. MSCs for these trials are isolated from harvested BM and then processed and expanded for intracardiac injection. The BM-MSCs in use for the clinical trials are of clinical grade having been processed successfully in an FDA-approved cGMP facility.",
keywords = "BM MSC, cGMP, cGTP, CMC, FDA, HCT/P, HF, IND, MI",
author = "{Da Silva}, {Jose S.} and Joshua Hare",
year = "2013",
doi = "10.1007/978-1-62703-505-7_8",
language = "English (US)",
isbn = "9781627035040",
volume = "1037",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "145--163",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Cell-based therapies for myocardial repair

T2 - Emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart

AU - Da Silva, Jose S.

AU - Hare, Joshua

PY - 2013

Y1 - 2013

N2 - Accumulating data support the use of bone marrow (BM)-derived MSCs in animal models (e.g., swine) to restore cardiac function and tissue perfusion in chronic cardiac injury. Based on results obtained in swine, we are currently conducting phase I/II clinical trials to address the safety, cell type, cell dose, delivery technique, and efficacy of MSCs in patients with chronic heart failure. MSCs for these trials are isolated from harvested BM and then processed and expanded for intracardiac injection. The BM-MSCs in use for the clinical trials are of clinical grade having been processed successfully in an FDA-approved cGMP facility.

AB - Accumulating data support the use of bone marrow (BM)-derived MSCs in animal models (e.g., swine) to restore cardiac function and tissue perfusion in chronic cardiac injury. Based on results obtained in swine, we are currently conducting phase I/II clinical trials to address the safety, cell type, cell dose, delivery technique, and efficacy of MSCs in patients with chronic heart failure. MSCs for these trials are isolated from harvested BM and then processed and expanded for intracardiac injection. The BM-MSCs in use for the clinical trials are of clinical grade having been processed successfully in an FDA-approved cGMP facility.

KW - BM MSC

KW - cGMP

KW - cGTP

KW - CMC

KW - FDA

KW - HCT/P

KW - HF

KW - IND

KW - MI

UR - http://www.scopus.com/inward/record.url?scp=84934439637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934439637&partnerID=8YFLogxK

U2 - 10.1007/978-1-62703-505-7_8

DO - 10.1007/978-1-62703-505-7_8

M3 - Chapter

SN - 9781627035040

VL - 1037

T3 - Methods in Molecular Biology

SP - 145

EP - 163

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -